This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Jan;125(1):2-3.

doi: 10.1016/j.ophtha.2017.11.008.

The Temin Effect

David Epstein¹, Malcolm Gladwell²

Affiliations

PMID: 29268864
DOI: 10.1016/j.ophtha.2017.11.008

Editorial

The Temin Effect

David Epstein et al. Ophthalmology. 2018 Jan.

. 2018 Jan;125(1):2-3.

doi: 10.1016/j.ophtha.2017.11.008.

Authors

David Epstein¹, Malcolm Gladwell²

Affiliations

¹ Washington, DC.
² New York, New York. Electronic address: malcolm@gladwell.com.

PMID: 29268864
DOI: 10.1016/j.ophtha.2017.11.008

No abstract available

PubMed Disclaimer

Comment on

Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study.
Silva R, Berta A, Larsen M, Macfadden W, Feller C, Monés J; TREND Study Group. Silva R, et al. Ophthalmology. 2018 Jan;125(1):57-65. doi: 10.1016/j.ophtha.2017.07.014. Epub 2017 Oct 12. Ophthalmology. 2018. PMID: 28893454 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations